alanine has been researched along with Cirrhosis, Liver in 42 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Enzymatic analysis of aspartate/alanine aminotransferase (AST/ALT) does not exactly represent the progression of liver fibrosis or inflammation." | 7.96 | Immunological measurement of aspartate/alanine aminotransferase in predicting liver fibrosis and inflammation. ( Baik, GH; Bang, CS; Choi, EY; Ham, YL; Kim, DJ; Kim, HJ; Kim, SY; Shin, SP; Suk, KT; Yang, YJ, 2020) |
| "A three-compartment model was used to analyse the urea response to an alanine infusion in control subjects and patients with liver cirrhosis." | 7.68 | Mathematical model to analyse urea synthesis following alanine infusion in control subjects and in patients with liver cirrhosis. ( Bianchi, GP; Bolzani, R; Marchesini, G; Sarti, E, 1990) |
| "In noninvasive measurement of liver fibrosis (FibroScan®), the level of liver stiffness measurement (LSM) had decreased significantly at 48 weeks (5." | 7.11 | Efficacy and safety of AnluoHuaxian pills on chronic hepatitis B with normal or minimally elevated alanine transaminase and early liver fibrosis: A randomized controlled trial. ( Cai, GS; Chen, HJ; Chen, JZ; Chen, L; Chi, XL; Gao, YQ; Guo, H; Jiang, JM; Lei, CL; Li, Q; Liu, HB; Lu, W; Mao, DW; Ou-Yang, WW; Shi, MJ; Tian, GJ; Wang, J; Wen, ZH; Wu, SD; Xiao, HM; Xie, YB; Xue, JD; Yang, HZ; Zhang, CZ; Zhao, PT, 2022) |
| "Enzymatic analysis of aspartate/alanine aminotransferase (AST/ALT) does not exactly represent the progression of liver fibrosis or inflammation." | 3.96 | Immunological measurement of aspartate/alanine aminotransferase in predicting liver fibrosis and inflammation. ( Baik, GH; Bang, CS; Choi, EY; Ham, YL; Kim, DJ; Kim, HJ; Kim, SY; Shin, SP; Suk, KT; Yang, YJ, 2020) |
| "A three-compartment model was used to analyse the urea response to an alanine infusion in control subjects and patients with liver cirrhosis." | 3.68 | Mathematical model to analyse urea synthesis following alanine infusion in control subjects and in patients with liver cirrhosis. ( Bianchi, GP; Bolzani, R; Marchesini, G; Sarti, E, 1990) |
| "In noninvasive measurement of liver fibrosis (FibroScan®), the level of liver stiffness measurement (LSM) had decreased significantly at 48 weeks (5." | 3.11 | Efficacy and safety of AnluoHuaxian pills on chronic hepatitis B with normal or minimally elevated alanine transaminase and early liver fibrosis: A randomized controlled trial. ( Cai, GS; Chen, HJ; Chen, JZ; Chen, L; Chi, XL; Gao, YQ; Guo, H; Jiang, JM; Lei, CL; Li, Q; Liu, HB; Lu, W; Mao, DW; Ou-Yang, WW; Shi, MJ; Tian, GJ; Wang, J; Wen, ZH; Wu, SD; Xiao, HM; Xie, YB; Xue, JD; Yang, HZ; Zhang, CZ; Zhao, PT, 2022) |
| "Patients with HCV GT3 infection and/or liver cirrhosis were excluded." | 2.90 | JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-Infected Patients Without Cirrhosis: OMEGA-1. ( Ackaert, O; Aghemo, A; Beumont, M; Biermer, M; Bourgeois, S; Buggisch, P; Buti, M; Corbett, C; Fevery, B; Greenbloom, S; Janczewska, E; Kalmeijer, R; Lampertico, P; Lim, SG; Moreno, C; Ouwerkerk-Mahadevan, S; Sinha, R; Tam, E; Vijgen, L; Willems, W; Zeuzem, S, 2019) |
| "AL-335 was well tolerated when administered as single and multiple doses, with an acceptable pharmacokinetic profile." | 2.87 | Safety, tolerability, and pharmacokinetics of AL-335 in healthy volunteers and hepatitis C virus-infected subjects. ( Astruc, B; Beigelman, L; Berliba, E; Blatt, LM; Chanda, S; Fry, J; Kakuda, TN; Khorlin, N; McClure, MW; Patat, A; Streinu-Cercel, A; Tsertsvadze, T; Vijgen, L; Vuong, J; Westland, C; Zhang, Q, 2018) |
| "Overall, patients with NAFLD and fibrosis had similar adiponectin concentrations with patients with NAFLD without fibrosis." | 2.82 | Circulating adiponectin in patients with nonalcoholic fatty liver disease-related liver fibrosis: A systematic review and a meta-analysis. ( Evripidou, K; Goulas, A; Goulis, DG; Makri, ES; Polyzos, SA; Tontikidou, C, 2022) |
| "To evaluate the impact of chronic hepatitis B virus infection (CHB) treatment on risk of cirrhosis, liver-related outcomes, and death among a diverse CHB cohort with a large proportion of African Americans." | 1.62 | Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems. ( Jain, MK; Kshirsagar, O; Niu, B; Thamer, M; Therapondos, G; Wong, RJ, 2021) |
| "Brivanib is a selective inhibitor of vascular endothelial growth factor receptor (VEGFR) and fibroblast growth factor receptor (FGFR) tyrosine kinases, which are both involved in mechanisms of liver fibrosis." | 1.40 | Brivanib attenuates hepatic fibrosis in vivo and stellate cell activation in vitro by inhibition of FGF, VEGF and PDGF signaling. ( Banini, BA; Kim, TH; Mikhail, DS; Moser, CD; Nakamura, I; Roberts, LR; Shaleh, HM; Thornburgh, SR; Walters, I; Yang, JD; Zakharia, K, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (33.33) | 18.7374 |
| 1990's | 7 (16.67) | 18.2507 |
| 2000's | 7 (16.67) | 29.6817 |
| 2010's | 5 (11.90) | 24.3611 |
| 2020's | 9 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Xiao, HM | 1 |
| Shi, MJ | 1 |
| Jiang, JM | 1 |
| Cai, GS | 1 |
| Xie, YB | 1 |
| Tian, GJ | 1 |
| Xue, JD | 1 |
| Mao, DW | 1 |
| Li, Q | 1 |
| Yang, HZ | 1 |
| Guo, H | 1 |
| Lei, CL | 1 |
| Lu, W | 1 |
| Chen, L | 1 |
| Liu, HB | 1 |
| Wang, J | 1 |
| Gao, YQ | 1 |
| Chen, JZ | 1 |
| Wu, SD | 1 |
| Chen, HJ | 1 |
| Zhao, PT | 1 |
| Zhang, CZ | 1 |
| Ou-Yang, WW | 1 |
| Wen, ZH | 1 |
| Chi, XL | 1 |
| Tontikidou, C | 1 |
| Makri, ES | 1 |
| Evripidou, K | 1 |
| Goulis, DG | 1 |
| Goulas, A | 1 |
| Polyzos, SA | 1 |
| Takehara, T | 1 |
| Chayama, K | 1 |
| Kurosaki, M | 1 |
| Yatsuhashi, H | 1 |
| Tanaka, Y | 1 |
| Hiramatsu, N | 1 |
| Sakamoto, N | 2 |
| Asahina, Y | 1 |
| Nozaki, A | 1 |
| Nakano, T | 1 |
| Hagiwara, Y | 1 |
| Shimizu, H | 1 |
| Yoshida, H | 1 |
| Huang, Y | 1 |
| Biermer, M | 2 |
| Vijgen, L | 3 |
| Hayashi, N | 1 |
| Sung, PS | 1 |
| Lee, CJ | 1 |
| Qiu, TA | 1 |
| Sweedler, JV | 1 |
| Wong, RJ | 1 |
| Jain, MK | 1 |
| Therapondos, G | 1 |
| Niu, B | 1 |
| Kshirsagar, O | 1 |
| Thamer, M | 1 |
| Umemura, T | 1 |
| Nishikawa, K | 1 |
| Mutoh, Y | 1 |
| Sasano, H | 1 |
| Kozaki, K | 1 |
| Yamada, T | 1 |
| Ichihara, T | 1 |
| Ding, Y | 1 |
| Lin, H | 1 |
| Chen, X | 1 |
| Zhu, B | 1 |
| Xu, X | 2 |
| Shen, W | 1 |
| Gao, M | 1 |
| He, N | 1 |
| McClure, MW | 1 |
| Berliba, E | 1 |
| Tsertsvadze, T | 1 |
| Streinu-Cercel, A | 1 |
| Astruc, B | 1 |
| Patat, A | 1 |
| Westland, C | 1 |
| Chanda, S | 1 |
| Zhang, Q | 1 |
| Kakuda, TN | 1 |
| Vuong, J | 1 |
| Khorlin, N | 1 |
| Beigelman, L | 1 |
| Blatt, LM | 1 |
| Fry, J | 1 |
| Kim, HJ | 1 |
| Kim, SY | 1 |
| Shin, SP | 1 |
| Yang, YJ | 1 |
| Bang, CS | 1 |
| Baik, GH | 1 |
| Kim, DJ | 1 |
| Ham, YL | 1 |
| Choi, EY | 1 |
| Suk, KT | 1 |
| Zeuzem, S | 1 |
| Bourgeois, S | 1 |
| Greenbloom, S | 1 |
| Buti, M | 1 |
| Aghemo, A | 1 |
| Lampertico, P | 1 |
| Janczewska, E | 1 |
| Lim, SG | 1 |
| Moreno, C | 1 |
| Buggisch, P | 1 |
| Tam, E | 1 |
| Corbett, C | 1 |
| Willems, W | 1 |
| Fevery, B | 1 |
| Ouwerkerk-Mahadevan, S | 1 |
| Ackaert, O | 1 |
| Beumont, M | 1 |
| Kalmeijer, R | 1 |
| Sinha, R | 1 |
| Lin, HC | 1 |
| Huang, YT | 1 |
| Yang, YY | 1 |
| Lee, PC | 1 |
| Hwang, LH | 1 |
| Lee, WP | 1 |
| Kuo, YJ | 1 |
| Lee, KC | 1 |
| Hsieh, YC | 1 |
| Liu, RS | 1 |
| Nakamura, I | 1 |
| Zakharia, K | 1 |
| Banini, BA | 1 |
| Mikhail, DS | 1 |
| Kim, TH | 1 |
| Yang, JD | 1 |
| Moser, CD | 1 |
| Shaleh, HM | 1 |
| Thornburgh, SR | 1 |
| Walters, I | 1 |
| Roberts, LR | 1 |
| Zakaria, S | 1 |
| El-Sisi, A | 1 |
| Kinjo, N | 1 |
| Kawanaka, H | 1 |
| Akahoshi, T | 1 |
| Yamaguchi, S | 1 |
| Yoshida, D | 1 |
| Anegawa, G | 1 |
| Konishi, K | 1 |
| Tomikawa, M | 1 |
| Tanoue, K | 1 |
| Tarnawski, A | 1 |
| Hashizume, M | 1 |
| Maehara, Y | 1 |
| Stewart, SF | 1 |
| Leathart, JB | 1 |
| Chen, Y | 1 |
| Daly, AK | 1 |
| Rolla, R | 1 |
| Vay, D | 1 |
| Mottaran, E | 1 |
| Vidali, M | 1 |
| Albano, E | 1 |
| Day, CP | 1 |
| Tietge, UJ | 1 |
| Bahr, MJ | 1 |
| Manns, MP | 1 |
| Böker, KH | 1 |
| MONDEN, M | 1 |
| KNAUFF, HG | 1 |
| SEYBOLD, D | 1 |
| MILLER, B | 1 |
| Shangraw, RE | 1 |
| Jahoor, F | 1 |
| Stickel, F | 1 |
| Osterreicher, CH | 1 |
| Datz, C | 1 |
| Ferenci, P | 1 |
| Wölfel, M | 1 |
| Norgauer, W | 1 |
| Kraus, MR | 1 |
| Wrba, F | 1 |
| Hellerbrand, C | 1 |
| Schuppan, D | 1 |
| Kume, H | 1 |
| Okazaki, K | 1 |
| Sasaki, H | 1 |
| Nishimura, A | 1 |
| Perier, C | 1 |
| Gautier, M | 1 |
| Baril, A | 1 |
| Bayle, JJ | 1 |
| Patouillard, G | 1 |
| Frey, J | 1 |
| Hagenfeldt, L | 1 |
| Wahren, J | 1 |
| Elia, M | 1 |
| Ilic, V | 1 |
| Bacon, S | 1 |
| Williamson, DH | 1 |
| Smith, R | 1 |
| Fabbri, A | 4 |
| Bianchi, GP | 2 |
| Brizi, M | 2 |
| Bugianesi, E | 2 |
| Grossi, G | 1 |
| Flamia, R | 1 |
| Zoli, M | 4 |
| Marchesini, G | 5 |
| Hamberg, O | 1 |
| Vilstrup, H | 2 |
| Bianchi, G | 3 |
| Bortoluzzi, L | 1 |
| Pisi, E | 2 |
| Nomura, H | 1 |
| Miyake, K | 1 |
| Hirakata, R | 1 |
| Migita, S | 1 |
| Okamoto, O | 1 |
| Shiraishi, G | 1 |
| Changani, KK | 1 |
| Jalan, R | 1 |
| Cox, IJ | 1 |
| Ala-Korpela, M | 1 |
| Bhakoo, K | 1 |
| Taylor-Robinson, SD | 1 |
| Bell, JD | 1 |
| Johnston, DG | 1 |
| Alberti, KG | 1 |
| Ganda, OP | 1 |
| Ruderman, NB | 1 |
| De Mitri, MS | 1 |
| Bolzani, R | 1 |
| Sarti, E | 1 |
| Hattori, T | 1 |
| Hotta, N | 1 |
| Ohara, K | 1 |
| Shinoda, H | 1 |
| Kunieda, T | 1 |
| Nomura, T | 1 |
| Kakuta, H | 1 |
| Tamagawa, T | 1 |
| Busuttil, A | 1 |
| Alston, WC | 1 |
| Horne, CH | 1 |
| MacSween, RN | 1 |
| Peters, JE | 2 |
| Nilius, R | 1 |
| Otto, L | 1 |
| Burchardt, U | 1 |
| Thulin, H | 1 |
| Sherwin, R | 1 |
| Joshi, P | 1 |
| Hendler, R | 1 |
| Felig, P | 1 |
| Conn, HO | 1 |
| Schlaeger, R | 1 |
| Kattermann, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Double-blind, Placebo-controlled, First-in-human, 3 Part Study of Orally Administered AL-335 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Dosing and Food-effect in Healthy Volunteers, and Multiple Ascending [NCT02339207] | Phase 1 | 112 participants (Actual) | Interventional | 2014-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for alanine and Cirrhosis, Liver
| Article | Year |
|---|---|
Circulating adiponectin in patients with nonalcoholic fatty liver disease-related liver fibrosis: A systematic review and a meta-analysis.
Topics: Adiponectin; Adolescent; Adult; Alanine; Alanine Transaminase; Aspartate Aminotransferases; Child; H | 2022 |
d-Alanine: Distribution, origin, physiological relevance, and implications in disease.
Topics: Alanine; Animals; Diabetes Mellitus; Humans; Kidney Diseases; Liver Cirrhosis; Mental Disorders; Neo | 2020 |
Carbohydrate metabolism in liver disease.
Topics: Alanine; Alcoholism; Animals; Blood Glucose; Carbohydrate Metabolism; Disease Models, Animal; Fastin | 1976 |
6 trials available for alanine and Cirrhosis, Liver
| Article | Year |
|---|---|
Efficacy and safety of AnluoHuaxian pills on chronic hepatitis B with normal or minimally elevated alanine transaminase and early liver fibrosis: A randomized controlled trial.
Topics: Alanine; Alanine Transaminase; Drugs, Chinese Herbal; Hepatitis B, Chronic; Humans; Liver; Liver Cir | 2022 |
JNJ-4178 (adafosbuvir, odalasvir, and simeprevir) in Japanese patients with chronic hepatitis C virus genotype 1 or 2 infection with or without compensated cirrhosis: the Phase IIa OMEGA-3 study.
Topics: Adult; Aged; Alanine; Antiviral Agents; Benzimidazoles; Carbamates; Drug Combinations; Female; Follo | 2020 |
Safety, tolerability, and pharmacokinetics of AL-335 in healthy volunteers and hepatitis C virus-infected subjects.
Topics: Adult; Alanine; Antiviral Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gen | 2018 |
JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-Infected Patients Without Cirrhosis: OMEGA-1.
Topics: Adult; Aged; Alanine; Antiviral Agents; Benzimidazoles; Carbamates; Dose-Response Relationship, Drug | 2019 |
Mechanism of dichloroacetate-induced hypolactatemia in humans with or without cirrhosis.
Topics: Adult; Alanine; C-Peptide; Dichloroacetic Acid; Female; Gas Chromatography-Mass Spectrometry; Glucag | 2004 |
Rebamipide prevents occurrence of gastric lesions following transcatheter arterial embolization in the hepatic artery.
Topics: Adult; Aged; Alanine; Carcinoma, Hepatocellular; Embolization, Therapeutic; Esophageal and Gastric V | 1999 |
33 other studies available for alanine and Cirrhosis, Liver
| Article | Year |
|---|---|
A different detection method reveals a new role of alanine aminotransferase as an indicator of liver fibrosis.
Topics: Alanine; Alanine Transaminase; Aspartate Aminotransferases; Aspartic Acid; Humans; Inflammation; Liv | 2020 |
Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems.
Topics: Adult; Aged; Alanine; Antiviral Agents; Asian; Black or African American; Carcinoma, Hepatocellular; | 2021 |
Usage experience of remdesivir for SARS-CoV-2 infection in a patient with chronic cirrhosis of Child-Pugh class C.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19 Drug Treatment; Humans; Liver Cirrhosis | 2021 |
Comprehensive metabolomics profiling reveals common metabolic alterations underlying the four major non-communicable diseases in treated HIV infection.
Topics: Adolescent; Adult; Aged; Alanine; Aspartic Acid; Atherosclerosis; Cognitive Dysfunction; Female; Glu | 2021 |
Immunological measurement of aspartate/alanine aminotransferase in predicting liver fibrosis and inflammation.
Topics: Alanine; Alanine Transaminase; Aspartate Aminotransferases; Aspartic Acid; Biomarkers; Biopsy; Hepat | 2020 |
Beneficial effects of dual vascular endothelial growth factor receptor/fibroblast growth factor receptor inhibitor brivanib alaninate in cirrhotic portal hypertensive rats.
Topics: Alanine; Animals; Cell Proliferation; Cells, Cultured; Hepatic Stellate Cells; Hypertension, Portal; | 2014 |
Brivanib attenuates hepatic fibrosis in vivo and stellate cell activation in vitro by inhibition of FGF, VEGF and PDGF signaling.
Topics: Alanine; Animals; Carbon Tetrachloride Poisoning; Cell Line; Cell Proliferation; Cell Survival; Coll | 2014 |
Rebamipide retards CCl4-induced hepatic fibrosis in rats: Possible role for PGE2.
Topics: Alanine; Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Carbo | 2016 |
Significance of ERK nitration in portal hypertensive gastropathy and its therapeutic implications.
Topics: Alanine; Animals; Enzyme Inhibitors; Ethanol; Extracellular Signal-Regulated MAP Kinases; Gastric Mu | 2008 |
Valine-alanine manganese superoxide dismutase polymorphism is not associated with alcohol-induced oxidative stress or liver fibrosis.
Topics: Alanine; Cardiolipins; Ethanol; Female; Genotype; Hepatitis, Alcoholic; Heterozygote; Homozygote; Hu | 2002 |
Altered alanine plasma levels despite normalized hepatic alanine extraction in the long-term course after liver transplantation.
Topics: Adult; Alanine; Female; Glucose; Humans; Liver; Liver Circulation; Liver Cirrhosis; Liver Transplant | 2003 |
[A STUDY OF THE FREE AMINO ACIDS IN THE SERUM OF LIVER DISEASES].
Topics: Alanine; Amino Acids; Ammonia; Animals; Arginine; Blood; Carbon Tetrachloride; Chemical and Drug Ind | 1964 |
[FREE PLASMA AMINO ACIDS IN LIVER CIRRHOSIS AND HEPATITIS].
Topics: Alanine; Amino Acids; Blood; Chromatography; Glutamine; Glycine; Hepatitis; Humans; Ion Exchange Res | 1964 |
Prediction of progression to cirrhosis by a glutathione S-transferase P1 polymorphism in subjects with hereditary hemochromatosis.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Disease Progression; Female; Genotype; Glutathione Transfer | 2005 |
Hepatoprotective effects of whey protein on D-galactosamine-induced hepatitis and liver fibrosis in rats.
Topics: Alanine; Animals; Aspartate Aminotransferases; Bilirubin; Chemical and Drug Induced Liver Injury; Di | 2006 |
[Studies on hepatic gluconeogenesis in chronic liver diseases; with special references to the effects of L-alanine administration].
Topics: Alanine; Carcinoma, Hepatocellular; Chronic Disease; Gluconeogenesis; Hepatitis, Chronic; Humans; Li | 1984 |
Measurement of changes in amino acids related to total collagen in fibrotic human liver.
Topics: Adult; Alanine; Amino Acids; Bile Ducts; Biopsy; Child; Child, Preschool; Chromatography, Gas; Colla | 1984 |
Experimental studies on the metabolic effects of branched chain amino acids.
Topics: Alanine; Amino Acids, Branched-Chain; Humans; Kidney; Kinetics; Leucine; Liver Cirrhosis; Parenteral | 1980 |
Relationship between the basal blood alanine concentration and the removal of an alanine load in various clinical states in man.
Topics: Adolescent; Adult; Aged; Alanine; Basal Metabolism; Blood Glucose; Diabetes Mellitus; Female; Half-L | 1980 |
Effects of beta-blockade on hepatic conversion of amino acid nitrogen and on urea synthesis in cirrhosis.
Topics: Aged; Alanine; Amino Acids; Blood Pressure; Catecholamines; Female; Heart Rate; Humans; Liver; Liver | 1995 |
Effects of glucose on hepatic conversion of aminonitrogen to urea in patients with cirrhosis: relationship to glucagon.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Amino Acids; Blood Glucose; Female; Glucagon; Glucose; Huma | 1994 |
Unresponsiveness of hepatic nitrogen metabolism to glucagon infusion in patients with cirrhosis: dependence on liver cell failure.
Topics: Adult; Alanine; Amino Acids; Glucagon; Humans; Kinetics; Liver; Liver Cirrhosis; Male; Metabolic Cle | 1993 |
Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis.
Topics: Administration, Oral; Adult; Aged; Alanine; Ammonia; Female; Glucagon; Hepatic Encephalopathy; Human | 1996 |
Evidence for altered hepatic gluconeogenesis in patients with cirrhosis using in vivo 31-phosphorus magnetic resonance spectroscopy.
Topics: Adult; Alanine; Analysis of Variance; Area Under Curve; Case-Control Studies; Fourier Analysis; Gluc | 2001 |
Muscle nitrogen metabolism in chronic hepatic insufficiency.
Topics: Adult; Aged; Alanine; Alcoholism; Amino Acids; Ammonia; Brachial Artery; Female; Forearm; Glutamine; | 1976 |
Hepatic amino-nitrogen clearance to urea-nitrogen in control subjects and in patients with cirrhosis: a simplified method.
Topics: Adult; Aged; Alanine; Amino Acids; Female; Galactose; Humans; Liver Cirrhosis; Male; Metabolic Clear | 1991 |
Mathematical model to analyse urea synthesis following alanine infusion in control subjects and in patients with liver cirrhosis.
Topics: Alanine; Discriminant Analysis; Humans; Liver Cirrhosis; Mathematics; Models, Biological; Urea | 1990 |
Pancreatic alpha- and beta-cell function and metabolic changes during oral L-alanine and glucose administration: comparative studies between normal, diabetic and cirrhotic subjects.
Topics: Administration, Oral; Adult; Alanine; Blood Glucose; Diabetes Mellitus; Female; Glucose; Glucose Tol | 1989 |
Effect of the production of experimental cirrhosis in rats on serum aminotransferase levels.
Topics: Alanine; Animals; Aspartic Acid; Carbon Tetrachloride; Drug Synergism; Kinetics; Liver Cirrhosis; Ph | 1972 |
[Electrophoretic variants of alanine aminopeptidase in serum of patients with hepatobiliary diseases].
Topics: Alanine; Aminopeptidases; Biliary Tract Diseases; Electrophoresis; Gallbladder Diseases; Hepatitis; | 1973 |
[Urinary enzyme determinations in hepatobiliary diseases].
Topics: Alanine; Aminopeptidases; Biliary Tract Diseases; Glucuronidase; Hepatitis A; Humans; Liver Cirrhosi | 1973 |
Hyperglucagonemia in Laennec's cirrhosis. The role of portal-systemic shunting.
Topics: Adolescent; Adult; Aged; Alanine; Alcoholism; Amino Acids; Ammonia; Blood Glucose; Esophageal and Ga | 1974 |
[Arylamidase and its isoenzymes in diseases of the pancreas and liver].
Topics: Acute Disease; Agar; Alanine; Alkaline Phosphatase; Amides; Aminohydrolases; Anilides; Cholestasis; | 1971 |